Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatuline Autogel pilot study in active moderate thyroid-associated ophthalmopathy
2004-003937-14Phase 2Completed
- Sponsor
- Ipsen
- Start
- Sep 2005
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Graves Orbitopathy (GO) comparing Somatuline Autogel with Placebo (2 arms). Primary endpoints: Primary efficacy assessment of orbital edema and infiltration, Primary assessment of proptosis and 2 more. Started Sep 2005; status: completed.
02
Drugs
lanreotide
03
Conditions
Graves Orbitopathy (GO)
Beyond the preview
Go deeper on 2004-003937-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003937-14.